These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4555041)

  • 41. [Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
    Zaworski C
    Gruzlica; 1967 May; 35(5):441-5. PubMed ID: 6056258
    [No Abstract]   [Full Text] [Related]  

  • 42. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 43. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 44. [The importance of initial chemotherapy in tuberculosis control programs].
    Anastasatu C
    Ann Ist Super Sanita; 1966; 2(2):458-70. PubMed ID: 4309078
    [No Abstract]   [Full Text] [Related]  

  • 45. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
    Kuczborski S
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):339-41. PubMed ID: 5897864
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
    Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
    Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
    [No Abstract]   [Full Text] [Related]  

  • 48. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN
    Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical efficiency of cycloserine in association with other tuberculostatics.
    Anastasatu C; Ulpian C; Weiss P
    Scand J Respir Dis Suppl; 1970; 71():152-4. PubMed ID: 5271976
    [No Abstract]   [Full Text] [Related]  

  • 50. Pyrazinamide-isoniazid: its apparent influence on the reactivation rate in pulmonary tuberculosis.
    Phillips S
    Am Rev Respir Dis; 1967 Mar; 95(3):503-5. PubMed ID: 6066869
    [No Abstract]   [Full Text] [Related]  

  • 51. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
    Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
    Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract]   [Full Text] [Related]  

  • 54. Short course chemotherapy of pulmonary tuberculosis and its possible impact on epidemiology of disease.
    Mehrotra ML; Gautam KD; Chaube CK
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):195-202. PubMed ID: 7166353
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effectiveness of antibacterial therapy of lung tuberculosis in degenerated stage in children and adolescence].
    Nabokova LS
    Pediatr Akus Ginekol; 1968; 5():5-6. PubMed ID: 5310924
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of chemotherapeutic agents on the dynamics of Mycobacterium tuberculosis antigen titers in organ homogenates during treatment of and following recovery from experimental tuberculosis].
    Romanova RIu
    Probl Tuberk; 1969; 47(3):74-8. PubMed ID: 5354638
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical aspects and outcome of recurrent pulmonary tuberculosis].
    Krasnov VA; Potashova VA; Zyrianova TV; Naryshkina SL
    Probl Tuberk; 1993; (5):14-6. PubMed ID: 8295875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognosis of pulmonary tuberculosis under modern treatment.
    Thomassen OK
    Scand J Respir Dis Suppl; 1968; 63():29-32. PubMed ID: 5188461
    [No Abstract]   [Full Text] [Related]  

  • 59. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 60. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.